C4 Therapeutics, Inc. (CCCC) is a biotechnology company focused on developing novel therapeutics based on protein degradation technology. Their platform enables the creation of small molecules that bind to target proteins and induce their selective degradation. This innovative therapeutic strategy has the potential to treat a wide range of diseases, including cancer and neurodegenerative disorders. C4 Therapeutics collaborates with major pharmaceutical companies to develop and commercialize new drug candidates. Their goal is to bring innovative treatment options to patients with various diseases. Shares of C4 Therapeutics, Inc. (CCCC) may be an attractive investment opportunity for investors interested in advanced therapeutic technologies and the biotechnology sector.